Miguel A. Martin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 220 publications
Assessment of microplastics accumulation and aging in horizontal subsurface flow constructed wetlands.
Journal: Water research
Published: February 17, 2026
Clinical features and management for CDK4/6 inhibitor-DILI.
Journal: JHEP reports : innovation in hepatology
Published: January 29, 2026
Sensitivity to Endocrine Therapy Index Predicts Benefit from Weekly Adjuvant Paclitaxel for Hormone Receptor-Positive Breast Cancer in the GEICAM/9906 Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 15, 2026
Genomic tests to guide management of breast cancer in Europe: regulation, reimbursement, adoption, and challenges.
Journal: Future oncology (London, England)
Published: November 06, 2025
Clinical and Molecular Evaluation of HER2-Low and HER2-Ultralow Breast Cancer in the Penelope-B Clinical Trial Cohort.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: November 05, 2025
Spatiotemporal trends of neglected tropical disease hospitalizations in Ecuador over 25-years from 2000 to 2024.
Journal: PLoS neglected tropical diseases
Published: October 25, 2025
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial.
Journal: JAMA oncology
Published: September 25, 2025
Patterns and Treatment Timelines of Tuberculosis in Males From Ecuador's Largest Prison.
Journal: Journal of correctional health care : the official journal of the National Commission on Correctional Health Care
Published: September 25, 2025
Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.
Journal: JCO precision oncology
Published: September 02, 2025
Antitumor activity of the combination of vinorelbine and gemcitabine in patients with HR + /HER2- advanced breast cancer after CDK4/6 inhibitor.
Journal: Breast cancer research and treatment
Published: July 14, 2025
Last Updated: 09/26/2026